BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 14264058)

  • 1. CYTOGENETICS OF MOUSE LEUKEMIA L1210. I. ASSOCIATION OF A SPECIFIC CHROMOSOME WITH DIHYDROFOLATE REDUCTASE ACTIVITY IN AMETHOPTERIN-TREATED SUBLINES.
    BIEDLER JL; ALBRECHT AM; HUTCHISON DJ
    Cancer Res; 1965 Feb; 25():246-57. PubMed ID: 14264058
    [No Abstract]   [Full Text] [Related]  

  • 2. ON THE SIMILARITY OF DIHYDROFOLATE REDUCTASES FROM AMETHOPTERIN-SENSITIVE AND AMETHOPTERIN-RESISTANT MOUSE LEUKEMIA (L1210) CELLS.
    KASHKET ER; CRAWFORD EJ; FRIEDKIN M; HUMPHREYS SR; GOLDIN A
    Biochemistry; 1964 Dec; 3():1928-31. PubMed ID: 14269312
    [No Abstract]   [Full Text] [Related]  

  • 3. ASSOCIATION OF INCREASED DIHYDROFOLATE REDUCTASE LEVELS AND CHROMOSOME ALTERATION IN AMETHOPTERIN-RESISTANT SUBLINES OF LEUKEMIA L1210.
    SCHRECKER AW; VENDITTI JM; GREENBERG NH; BIEDLER JL; ROBINSON DL; HUTCHISON DJ
    J Natl Cancer Inst; 1963 Sep; 31():557-74. PubMed ID: 14059003
    [No Abstract]   [Full Text] [Related]  

  • 4. SELECTION OF CHROMOSOMAL VARIANT IN AMETHOPTERIN-RESISTANT SUBLINES OF LEUKEMIA L1210 WITH INCREASED LEVELS OF DIHYDROFOLATE REDUCTASE.
    BIEDLER JL; SCHRECKER AW; HUTCHISON DJ
    J Natl Cancer Inst; 1963 Sep; 31():575-601. PubMed ID: 14059004
    [No Abstract]   [Full Text] [Related]  

  • 5. A DIRECT ASSAY FOR DIHYDROFOLATE REDUCTASE IN HUMAN LEUKOCYTES.
    MISRA DK
    Blood; 1964 May; 23():572-80. PubMed ID: 14142499
    [No Abstract]   [Full Text] [Related]  

  • 6. The association of increased dihydrofolate reductase with amethopterin resistance in mouse leukemia.
    FRIEDKIN M; CRAWFORD E; HUMPHREYS SR; GOLDIN A
    Cancer Res; 1962 Jun; 22():600-6. PubMed ID: 13895219
    [No Abstract]   [Full Text] [Related]  

  • 7. Variation of dihydrofolate reductase activity during in vitro and in vivo growth of sublines of L1210 lymphoma.
    Hillcoat BL
    J Natl Cancer Inst; 1971 Jan; 46(1):75-80. PubMed ID: 5546195
    [No Abstract]   [Full Text] [Related]  

  • 8. Interaction of 1,N6-ethenoadenine derivatives of triphosphopyridine and reduced triphosphopyridine nucleotides with dihydrofolate reductase from amethopterin-resistant L1210 cells.
    Neef VG; Huennekens FM
    Biochemistry; 1976 Sep; 15(18):4042-7. PubMed ID: 9129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic heterogeneity of dihydrofolate reductase from methotrexate sensitive and resistant L1210 leukemia cells.
    Iqbal MP; Rothenberg SP; Larosa C
    Proc Soc Exp Biol Med; 1985 Oct; 180(1):98-102. PubMed ID: 2412235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amethopterin-induced changes in the multiple forms of dihydrofolate reductase from L1210 cells.
    Harding NG; Martelli MF; Huennekens FM
    Arch Biochem Biophys; 1970 Mar; 137(1):295-6. PubMed ID: 5435066
    [No Abstract]   [Full Text] [Related]  

  • 11. Dialkyl esters of methotrexate and 3',5'-dichloromethotrexate: synthesis and interaction with aldehyde oxidase and dihydrofolate reductase.
    Johns DG; Farquhar D; Wolpert MK; Chabner BA; Loo TL
    Drug Metab Dispos; 1973; 1(3):580-9. PubMed ID: 4149453
    [No Abstract]   [Full Text] [Related]  

  • 12. CATALASE ACTIVITY IN MOUSE LEUKEMIA L1210.
    LOTTSFELDT FI; PEHOUSHEK C; KRIVIT W
    Cancer Res; 1965 Feb; 25():370-3. PubMed ID: 14264061
    [No Abstract]   [Full Text] [Related]  

  • 13. Dihydrofolate reductase activity of leukemia L1210 during development of methotrexate resistance.
    Schrecker AW; Mead JA; Greenberg NH; Goldin A
    Biochem Pharmacol; 1971 Mar; 20(3):716-8. PubMed ID: 5150168
    [No Abstract]   [Full Text] [Related]  

  • 14. Multiple forms of L1210 dihydrofolate reductase differing in affinity for methotrexate.
    Duffy TH; Beckman SB; Huennekens FM
    Biochem Biophys Res Commun; 1984 Feb; 119(1):352-8. PubMed ID: 6704125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of methotrexate polyglutamates in L1210 murine leukemia cells.
    Whitehead VM
    Cancer Res; 1977 Feb; 37(2):408-12. PubMed ID: 832265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative frequency and kinetic properties of transport-defective phenotypes among methotrexate-resistant L1210 clonal cell lines derived in vivo.
    Sirotnak FM; Moccio DM; Kelleher LE; Goutas LJ
    Cancer Res; 1981 Nov; 41(11 Pt 1):4447-52. PubMed ID: 7306968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LEVELS OF DIHYDROFOLATE REDUCTASE AND THE FORMATE-ACTIVATING ENZYME ACTIVITIES IN GUINEA PIG TISSUES BEFORE AND AFTER AMETHOPTERIN ADMINISTRATION.
    BERTINO JR; SIMMONS B; DONOHUE DM
    Biochem Pharmacol; 1964 Feb; 13():225-33. PubMed ID: 14127302
    [No Abstract]   [Full Text] [Related]  

  • 18. Antifolate polyglutamylation and competitive drug displacement at dihydrofolate reductase as important elements in leucovorin rescue in L1210 cells.
    Matherly LH; Barlowe CK; Goldman ID
    Cancer Res; 1986 Feb; 46(2):588-93. PubMed ID: 2416428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of intracellular conversion of dihydrohomofolate to tetrahydrohomofolate in leukemia cells with high levels of dihydrofolate reductase.
    Nahas A; Friedkin M
    Mol Pharmacol; 1972 May; 8(3):353-61. PubMed ID: 5040933
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison of dihydrofolate reductase activity in intact leukemia cells and squamous cell carcinoma.
    FitzGerald GB; Wick MM
    Anticancer Drug Des; 1989 Jun; 4(1):79-87. PubMed ID: 2757754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.